Can a Framework Be Established for the Safe Use of Ketamine?
Am J Psychiatry
.
2018 Jul 1;175(7):587-589.
doi: 10.1176/appi.ajp.2018.18030290.
Epub 2018 Apr 16.
Authors
Robert Freedman
1
,
Alan S Brown
1
,
Tyrone D Cannon
1
,
Benjamin G Druss
1
,
Felton J Earls
1
,
Javier Escobar
1
,
Yasmin L Hurd
1
,
David A Lewis
1
,
Carlos López-Jaramillo
1
,
Joan Luby
1
,
Helen S Mayberg
1
,
Terrie E Moffitt
1
,
Maria Oquendo
1
,
Roy H Perlis
1
,
Daniel S Pine
1
,
A John Rush
1
,
Carol A Tamminga
1
,
Mauricio Tohen
1
,
Eduard Vieta
1
,
Katherine L Wisner
1
,
Yu Xin
1
Affiliation
1
The authors are members of the Editorial Board of the Journal.
PMID:
29656666
DOI:
10.1176/appi.ajp.2018.18030290
No abstract available
Keywords:
Clinical Drug Studies; Psychoactive Substance Use Disorder.
Publication types
Editorial
Comment
MeSH terms
Depression
Depressive Disorder*
Double-Blind Method
Humans
Ketamine*
Substance-Related Disorders*
Suicide*
Substances
Ketamine
Grants and funding
MR/P005918/1/MRC_/Medical Research Council/United Kingdom